Earl S Ford1, Chaoyang Li, Guixiang Zhao, William S Pearson, Ali H Mokdad. 1. Division of Adult and Community Health, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia 30341, USA. eford@cdc.gov
Abstract
OBJECTIVE: Our objective was to estimate the prevalence of the metabolic syndrome using the 2007 pediatric International Diabetes Federation (IDF) definition among adolescents in the U.S. RESEARCH DESIGN AND METHODS: We used data from 2,014 participants aged 12-17 years of the National Health and Nutrition Examination Survey 1999-2004. RESULTS: The prevalence of the metabolic syndrome for the period 1999-2004 was approximately 4.5% ( approximately 1.1 million adolescents aged 12-17 years in 2006). It increased with age, was higher among males (6.7%) than females (2.1%) (P = 0.006), and was highest among Mexican-American adolescents (7.1%). The prevalence of the metabolic syndrome was relatively stable across the 6-year period: 4.5% for 1999-2000, 4.4-4.5% for 2001-2002, and 3.7-3.9% for 2003-2004 (P for linear trend >0.050). CONCLUSIONS: Our results provide the first estimates of the prevalence of the metabolic syndrome using the pediatric IDF definition among adolescents in the U.S.
OBJECTIVE: Our objective was to estimate the prevalence of the metabolic syndrome using the 2007 pediatric International Diabetes Federation (IDF) definition among adolescents in the U.S. RESEARCH DESIGN AND METHODS: We used data from 2,014 participants aged 12-17 years of the National Health and Nutrition Examination Survey 1999-2004. RESULTS: The prevalence of the metabolic syndrome for the period 1999-2004 was approximately 4.5% ( approximately 1.1 million adolescents aged 12-17 years in 2006). It increased with age, was higher among males (6.7%) than females (2.1%) (P = 0.006), and was highest among Mexican-American adolescents (7.1%). The prevalence of the metabolic syndrome was relatively stable across the 6-year period: 4.5% for 1999-2000, 4.4-4.5% for 2001-2002, and 3.7-3.9% for 2003-2004 (P for linear trend >0.050). CONCLUSIONS: Our results provide the first estimates of the prevalence of the metabolic syndrome using the pediatric IDF definition among adolescents in the U.S.
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Emelia J Benjamin; Jarett D Berry; William B Borden; Dawn M Bravata; Shifan Dai; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Elsayed Z Soliman; Paul D Sorlie; Nona Sotoodehnia; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2011-12-15 Impact factor: 29.690
Authors: Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett Journal: Circulation Date: 2010-12-15 Impact factor: 29.690
Authors: Alan S Go; Dariush Mozaffarian; Véronique L Roger; Emelia J Benjamin; Jarett D Berry; Michael J Blaha; Shifan Dai; Earl S Ford; Caroline S Fox; Sheila Franco; Heather J Fullerton; Cathleen Gillespie; Susan M Hailpern; John A Heit; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Rachel H Mackey; David J Magid; Gregory M Marcus; Ariane Marelli; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Michael E Mussolino; Robert W Neumar; Graham Nichol; Dilip K Pandey; Nina P Paynter; Matthew J Reeves; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Nathan D Wong; Daniel Woo; Melanie B Turner Journal: Circulation Date: 2013-12-18 Impact factor: 29.690
Authors: Christine Li; Boris Birmaher; Brian Rooks; Mary Kay Gill; Heather Hower; David A Axelson; Daniel P Dickstein; Tina R Goldstein; Fangzi Liao; Shirley Yen; Jeffrey Hunt; Satish Iyengar; Neal D Ryan; Michael A Strober; Martin B Keller; Benjamin I Goldstein Journal: J Clin Psychiatry Date: 2019-07-30 Impact factor: 4.384
Authors: Matthew D Hirschey; Tadahiro Shimazu; Enxuan Jing; Carrie A Grueter; Amy M Collins; Bradley Aouizerat; Alena Stančáková; Eric Goetzman; Maggie M Lam; Bjoern Schwer; Robert D Stevens; Michael J Muehlbauer; Sanjay Kakar; Nathan M Bass; Johanna Kuusisto; Markku Laakso; Frederick W Alt; Christopher B Newgard; Robert V Farese; C Ronald Kahn; Eric Verdin Journal: Mol Cell Date: 2011-10-21 Impact factor: 17.970